Indefinite Delivery Contract HHSN272201300023I

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Contract (IDC) known as the "Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016)" to Vanderbilt University Medical Center (VUMC), a nonprofit healthcare provider. This multiple-award IDC has a potential value of $200 million and no set-aside designation. Under this IDC, the CDC has issued two firm fixed-price delivery orders...

This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Trustees of Indiana University, doing business as Indiana University, to support the Vaccine Safety Datalink (VSD) program. The VSD is an ongoing collaboration between the CDC and several health care organizations to monitor the safety of vaccines and conduct epidemiological studies. Under the $149 million, multiple-award IDIQ contract, Indiana University will provide data infrastructure,...

The U.S. federal government agency has awarded an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) to Vanderbilt University Medical Center (VUMC) to develop an integrated antibody discovery platform capable of identifying antibodies with a high probability of efficacy and developability. The $18,293,274 ceiling value OT IDV is focused on PROTOTYPE ANTIBODY DISCOVERY and is funded by the Joint PEO Chemical and Biological Defense. As a prominent academic medical center and non-profit...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) awarded a single-award Blanket Purchase Agreement (BPA) to Euroimmun US Incorporated, a subsidiary of Revvity Inc., to provide T-SPOT TB reagents. The BPA has a total ceiling value of $1,128,588.50 and runs through September 2026, with three call orders totaling over $400,000 issued to date. The T-SPOT TB reagents will support tuberculosis screening and diagnostic testing...

The federal contract IDV award is for the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) program. The $346.6 million, multiple-award IDIQ contract was awarded to Icon Government And Public Health Solutions, Inc., a foreign-owned, for-profit organization that specializes in providing comprehensive clinical research services to federal agencies, particularly in the areas of medical countermeasure development and public health emergency...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $346.6 million multiple-award Indefinite Delivery Contract (IDC) called the Early Phase Clinical Trial Units (EPCTU) program. This IDC supports Phase 0 through Phase III clinical trials of investigational products against infectious diseases, including small molecules, monoclonal antibodies, vaccines, and other medical countermeasures. The prime...

The Department of Veterans Affairs Veterans Health Administration awarded a single award, firm fixed price Indefinite Delivery Contract to Vitalant Research Institute of Scottsdale, Arizona. The contract has a potential value of $1,679,700 to support the agency's Coronavirus COVID-19 national interest efforts through August 2021. Under the original solicitation, Vitalant will provide up to 1,200 units of 200mL bags of COVID-19 Convalescent Plasma for a 24-month VA clinical study to treat...

This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide centralized clinical laboratory services in support of clinical research trials. With a potential value of $5,000,000 and a period of performance through May 2026, the awardee PPD Development LP will deliver services including specimen handling, testing, data management, and clinical trial support. The originating...

The Centers for Disease Control and Prevention awarded Vanderbilt University Medical Center an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment base services from September 2023 through September 2028. Under this multiple award contract vehicle, VUMC will support CDC's immunization safety monitoring and vaccine safety research efforts. CDC also issued a $6.6 million delivery order to VUMC for Clinical Immunization Safety...

This Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Dynport Vaccine Company LLC, a subsidiary of General Dynamics. The contract, valued at a ceiling of $346,610,277, is for Early Phase Clinical Trial Units (EPCTU) services to support Phase 0 through Phase II clinical trials of investigational products targeting infectious diseases. The contract has a period of performance through...